An Open-Label, Phase I Clinical Trial of Super CAR-T With GPC3-Positive Advanced Hepatocellular Carcinoma

Summary

This study was a phase I safety and tolerability clinical trial conducted in a single-center, open-label, 3+3 design with dose escalation.

Timeline

Start

2026-03-27

Primary completion

2028-04-30

Completion

2028-07-30

Drugs

Indications